Bionano Genomics (BNGO) Change in Account Payables (2017 - 2026)

Bionano Genomics has disclosed Change in Account Payables across 10 years of filings, most recently posting -$528000.0 for Q1 2026.

• Change in Account Payables for Q1 2026 came in at -$528000.0, down 31.67% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.5 million (up 54.35% YoY), and the FY2025 annual result was -$1.4 million, up 59.88% from the prior year.
• Change in Account Payables came in at -$528000.0 for Q1 2026 at Bionano Genomics, down from -$399000.0 in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $3.2 million in Q3 2023 to a low of -$4.4 million in Q4 2023.
• The 5-year median for Change in Account Payables is -$399000.0 (2025), against an average of -$315647.1.
• Across the five-year window, Change in Account Payables surged 280.0% in 2023 and tumbled 719.35% in 2025, its largest moves.
• Bionano Genomics' Change in Account Payables stood at $3.2 million in 2022, then sank by 238.15% to -$4.4 million in 2023, then jumped by 60.4% to -$1.7 million in 2024, then surged by 77.08% to -$399000.0 in 2025, then slumped by 32.33% to -$528000.0 in 2026.
• The last three Change in Account Payables figures came in at -$528000.0 (Q1 2026), -$399000.0 (Q4 2025), and -$254000.0 (Q3 2025), per Business Quant data.